C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor

Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
12/2006
12/21/2006	DE102005027685A1 Verfahren zur Herstellung von Lipasen Process for the preparation of lipases
12/21/2006	CA2612514A1 Novel plants
12/21/2006	CA2612304A1 Sulfate ion transporter gene and use thereof
12/21/2006	CA2612281A1 Method for diagnosing alzheimer's disease
12/21/2006	CA2612200A1 Method of cancer treatment using sirna silencing
12/21/2006	CA2612180A1 Methods of treatment, and diagnosis of epilepsy by detecting mutations in the scn1a gene
12/21/2006	CA2612168A1 Methods for producing antibodies
12/21/2006	CA2612069A1 Antigen conjugates and uses thereof
12/21/2006	CA2612016A1 Lecitin-like protein kinase stress-related polypeptides and methods of use in plants
12/21/2006	CA2611954A1 Dengue serotype 2 attenuated strain
12/21/2006	CA2611951A1 Method of processing and/or genome mapping of ditag sequences
12/21/2006	CA2611930A1 Methods for increasing the resistance of plants to hypoxic conditions
12/21/2006	CA2611512A1 Methods for synthesis of encoded libraries
12/21/2006	CA2611486A1 Sclerotinia-resistant brassica and methods for development of resistance to sclerotinia
12/21/2006	CA2611054A1 Novel a.beta.-binding protein and its peptide derivatives and uses thereof
12/21/2006	CA2611048A1 Psp94 diagnostic reagents and assays
12/21/2006	CA2610919A1 Hepatitis c virus nucleic acid vaccine
12/21/2006	CA2606220A1 Starchy-endosperm and/or germinating embryo-specific expression in mono-cotyledonous plants
12/21/2006	CA2578844A1 Semi-soft c-class immunostimulatory oligonucleotides
12/21/2006	CA2574848A1 Antagonizing interleukin-21 receptor activity
12/20/2006	EP1734133A2 Heparanase specific molecular probes and their use in research and medical applications
12/20/2006	EP1734126A2 Regeneration
12/20/2006	EP1734125A1 Homeologous recombination in MSH2 inactivated plants or cells thereof
12/20/2006	EP1734124A1 Prostate specific antigen peptides and uses thereof
12/20/2006	EP1734123A1 Genetically engineered modification of potato to form amylopectin-type starch
12/20/2006	EP1734122A2 APO-2 ligand
12/20/2006	EP1734121A2 Genetically engineered human-derived Kunitz domains that inhibit human neutrophil elastase
12/20/2006	EP1734120A2 Reagents and methods for identifying and modulating expression of genes regulated by CDK inhibitors
12/20/2006	EP1734119A2 CD16-II variants
12/20/2006	EP1734118A1 Identification of JAK/STAT pathway modulating genes by genome wide RNAi screening
12/20/2006	EP1734117A1 Novel fluorescent protein and gene encoding the same
12/20/2006	EP1734116A2 Thrombin derivatives and medicinal composition containing the same
12/20/2006	EP1734112A1 Method of proliferating pluripotent stem cell
12/20/2006	EP1734054A2 Anti-human thymidylate synthase monoclonal antibody and hybridoma capable of producing the same
12/20/2006	EP1734053A2 Monoclonal antibodies that recognize flk-2 receptors and the isolation of primitive hematopoietic stem cell populations
12/20/2006	EP1734051A2 Composition and methods for the diagnosis of tumours
12/20/2006	EP1734050A2 Immunization of dairy cattle with GapC protein against streptococcus infection
12/20/2006	EP1734049A1 Tumour-associated peptides that bind to MHC-molecules
12/20/2006	EP1734048A1 Tumor-associated peptides that bind to MHC-molecules
12/20/2006	EP1733743A1 Preventives/remedies for cancer
12/20/2006	EP1733739A1 sFRP EXPRESSION POTENTIATING AGENT
12/20/2006	EP1733738A1 Method of preventing ultraviolet ray-induced apoptosis
12/20/2006	EP1733736A2 Method of producing recombinant antibodies against tumours
12/20/2006	EP1733055A2 Polynucleotide synthesis
12/20/2006	EP1733049A1 Method of diagnosis of a predisposition to develop thrombotic disease and its uses
12/20/2006	EP1733045A1 Design and therapeutic use of adpase enhanced apyrases
12/20/2006	EP1733040A2 Filamentous fungal mutants with improved homologous recombination efficiency
12/20/2006	EP1733039A2 Improved bacterial host cell for the direct expression of peptides
12/20/2006	EP1733038A2 Method for producing purine nucleosides and nucleotides by fermentation using bacterium belonging to the genus bacillus or escherichia
12/20/2006	EP1733037A2 Process for producing polypeptides
12/20/2006	EP1733036A2 Cancer prognosis and/or diagnosis method
12/20/2006	EP1733035A2 Modified polynucleotides for reducing off-target effects in rna interference
12/20/2006	EP1733034A2 Methods and constructs for expressing polypeptide multimers in eukaryotic cells using alternative splicing
12/20/2006	EP1733033A2 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same
12/20/2006	EP1733029A2 Pufa-pks genes from ulkenia
12/20/2006	EP1732996A2 Use of hydroxypropylated high amylose content potato starches to achieve high kit numbers
12/20/2006	EP1732952A2 Gold-binding protein and use thereof
12/20/2006	EP1732950A2 Antibodies to erythropoietin receptor and uses thereof
12/20/2006	EP1732946A2 Dimeric fusion proteins and materials and methods for producing them
12/20/2006	EP1732940A2 METHOD FOR CONSTRUCTION AND USE OF <i>KLUYVEROMYCES LACTIS</i> PROMOTER VARIANTS IN <i>K.LACTIS</i> THAT SUBSTANTIALLY LACK <i>E. COLI</i> TRANSCRIPTIONAL CAPABILITY
12/20/2006	EP1732650A1 Composition and method for cancer treatment
12/20/2006	EP1732649A1 Treatment of neurodegenerative diseases by the use of laptm4b
12/20/2006	EP1732615A2 Production of peptides in plants as viral coat protein fusion
12/20/2006	EP1732614A2 Methods and compositions for treating neuropathic and neurodegenerative conditions
12/20/2006	EP1732613A2 Use of serum albumin binding peptides conjugates for the preparation of a medicament
12/20/2006	EP1732591A2 Combined immunotherapy of fusion cells and interleukin-12 for treatment of cancer
12/20/2006	EP1732585A1 Polypeptide sequence involved in the modulation of the immunosuppresive effect of viral proteins
12/20/2006	EP1732571A2 Controlled modulation of the pharmacokinetics and biodistribution of aptamer therapeutics
12/20/2006	EP1732463A2 Instrument for delivery of optical energy to the dental root canal system for hidden bacterial and live biofilm thermolysis
12/20/2006	EP1732383A2 Prevention and treatment of vascular disease with recombinant adeno-associated virus vectors encoding apolipoprotein a-i and apolipoprotein a-i milano
12/20/2006	EP1732382A2 Sfec, a sperm flagellar energy carrier protein
12/20/2006	EP1732379A2 Compositions and methods for control of insect infestations in plants
12/20/2006	EP1732378A1 Plants having improved growth characteristics and method for making the same
12/20/2006	EP1732377A2 Cambium/xylem-preferred promoters and uses thereof
12/20/2006	EP1687421A4 A process for producing exogenous protein in the milk of trangenic mammals and a process for purifying proteins therefrom
12/20/2006	EP1660687A4 Rnai-based modification of heterochromatin
12/20/2006	EP1658309B1 Peptide protein translation inhibitor and the use thereof for protein translation control
12/20/2006	EP1578949A4 Site specific incorporation of keto amino acids into proteins
12/20/2006	EP1546385A4 Quantification of gene expression
12/20/2006	EP1481083B1 Detection of nucleic acids
12/20/2006	EP1472348B1 Ultraviolet light for light activated gene transduction in gene delivery
12/20/2006	EP1447449B1 PROCESSES FOR PRODUCING BETA-1,3-n-ACETYLGLUCOSAMINE TRANSFERASE AND N-ACETYLGLUCOSAMINE-CONTAINING COMPOSITE SACCHARIDE
12/20/2006	EP1444329B1 Stem cells that transform to beating cardiomyocytes
12/20/2006	EP1442124B1 Polypeptide antigen forming a mimetic structure of the gp41 intermediate state
12/20/2006	EP1430462A4 Printed materials comprising a support having an oligomer and/or a polymer applied thereon, a method for preparing the same and a method for delivering and/or storing the same
12/20/2006	EP1409652B1 Immortalized preosteoblasts and method for their production
12/20/2006	EP1321473B1 Method for preventing a freeze-induced decrease of the activity of a protein
12/20/2006	EP1317537B1 G-csf analog compositions and methods
12/20/2006	EP1299537B1 Compounds targeted to cellular locations
12/20/2006	EP1261719B1 27411, a human phosphatidyl-glycerolphosphate (pgp) synthase
12/20/2006	EP1147123B1 Novel odorant receptors in drosophila
12/20/2006	EP1135477B1 Humanized monoclonal integrin antibodies
12/20/2006	EP1023453B1 Tgc method for inducting targeted somatic transgenesis
12/20/2006	EP0972032B1 Peptides for the treatment of systemic lupus erythematosus
12/20/2006	EP0964916B1 Hbv mutants and methods for detecting same
12/20/2006	EP0942983B1 Streptococcus pneumoniae antigens and vaccines
12/20/2006	EP0842285B1 Root cortex specific gene promoter
12/20/2006	EP0839193B1 Porphyrin-accumulating type herbicide resistance gene
12/20/2006	EP0833660B1 Vectors for the diagnosis and treatment of solid tumors including melanoma
12/20/2006	CN1882704A A method for detecting nipah virus and method for providing immunoprotection against henipaviruses

1 ... 1689 1690 1691 1692 1693 1694 1695 1696 1697 1698 1699 1700 1701 1702 1703 1704 1705 1706 1707 1708 1709 ... 4023